Yu-Jen Chen

Yu-Jen Chen

Auto-generated profile, based on publicly available information

Yu-Jen Chen

Department of Biological Science and Technology, Institute of Molecular Medicine and Bioengineering, National Chiao Tung University, 75 Bo-Ai Street, Hsinchu 300, Taiwan

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2017 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
SPSathyadevi Palanisamy
Sathyadevi Palanisamy
PWPei-Yu Wu
Pei-Yu Wu
SWShou-Cheng Wu
Shou-Cheng Wu
YCYu-Jen Chen
Yu-Jen Chen
STShey-Cherng Tzou
Shey-Cherng Tzou
YWYun-Ming Wang
Yun-Ming Wang

30 August 2016 in Inorganic Chemistry
Verified
Journal Article
Closed access
SWShou-Cheng Wu
Shou-Cheng Wu
CLChung-Yen Lu
Chung-Yen Lu
YCYi-Lin Chen
Yi-Lin Chen
FLFeng-Chun Lo
Feng-Chun Lo
TWTing-Yin Wang
Ting-Yin Wang
YWYun-Ming Wang
Yun-Ming Wang

1 January 2016 in Talanta
Verified
Journal Article
Closed access
SPSathyadevi Palanisamy
Sathyadevi Palanisamy
LLLu-Ying Lee
Lu-Ying Lee
YWYu-Liang Wang
Yu-Liang Wang
YCYu-Jen Chen
Yu-Jen Chen
CCChiao-Yun Chen
Chiao-Yun Chen
YWYun-Ming Wang
Yun-Ming Wang

22 August 2019 in Molecular Pharmaceutics
Verified
Journal Article
Closed access
YCYu-Jen Chen
Yu-Jen Chen
SWShou-Cheng Wu
Shou-Cheng Wu
HWHsiang-Ching Wang
Hsiang-Ching Wang
TWTung-Ho Wu
Tung-Ho Wu
Shyng-Shiou YuanShyng-Shiou Yuan
Shyng-Shiou Yuan
YWYun-Ming Wang
Yun-Ming Wang

1 January 2016 in Theranostics
Verified
Journal Article
Open access
SWShou-Cheng Wu
Shou-Cheng Wu
YCYu-Jen Chen
Yu-Jen Chen
HWHsiang-Ching Wang
Hsiang-Ching Wang
MCMin-Yuan Chou
Min-Yuan Chou
TCTeng-Yuan Chang
Teng-Yuan Chang
YWYun-Ming Wang
Yun-Ming Wang
The overexpression of HER2/neu and EGFR receptors plays important roles in tumorigenesis and tumor progression. Targeting these two receptors simultaneously can have a more widespread application in early diagnosis of cancers. In this study, a new multifunctional nanoparticles (MnMEIO-CyTE777-(Bis)-mPEG NPs) comprising a manganese-doped iron oxide nanoparticle core (MnMEIO), a silane-amino functionalized poly(ethylene glycol) copolymer shell, a near infrared fluorescence dye (CyTE777), and a covalently conjugated anti-HER2/neu and anti-EGFR receptors bispecific antibody (Bis) were successfully developed. In vitro T2-weighted MR imaging studies in SKBR-3 and A431 tumor cells incubated with MnMEIO-CyTE777-(Bis)-mPEG NPs showed - 94.8 ± 3.8 and - 84.1 ± 2.8% negative contrast enhancement, respectively. Pharmacokinetics study showed that MnMEIO-CyTE777-(Bis)-mPEG NPs were eliminated from serum with the half-life of 21.3 mins. In vivo MR imaging showed that MnMEIO-CyTE777-(Bis)-mPEG NPs could specifically and effectively target to HER2/neu- and EGFR-expressing tumors in mice; the relative contrast enhancements were 11.8 (at 2 hrs post-injection) and 61.5 (at 24 hrs post-injection) fold higher in SKBR-3 tumors as compared to Colo-205 tumors. T2-weighted MR and optical imaging studies revealed that the new contrast agent (MnMEIO-CyTE777-(Bis)-mPEG NPs) could specifically and effectively target to HER2/neu- and/or EGFR-expressing tumors. Our results demonstrate that MnMEIO-CyTE777-(Bis)-mPEG NPs are able to recognize the tumors expressing both HER2/neu and/or EGFR, and may provide a novel molecular imaging tool for early diagnosis of cancers expressing HER2/neu and/or EGFR.

1 January 2014 in Biomaterials
Verified
Journal Article
Closed access
YCYu-Jen Chen
Yu-Jen Chen
SWShou-Cheng Wu
Shou-Cheng Wu
CCChung-Yung Chen
Chung-Yung Chen
STShey-Cherng Tzou
Shey-Cherng Tzou
TCTian-Lu Cheng
Tian-Lu Cheng
YWYun-Ming Wang
Yun-Ming Wang